The role of the tumor primary chemosensitivity relative to the success of the medical-surgical management in patients with advanced ovarian carcinomas

About 22,000 new cases of ovarian carcinomas are detected every year in the US [1]. It is considered that around 65% to 80% of patients are diagnosed with advanced stages III-IV diseases, depending on the pathology subtypes [1]. The backbone of the standard first-line treatment has historically relied on two components, with the combination of debulking surgery and systemic medical therapy.
Source: Cancer Treatment Reviews - Category: Cancer & Oncology Authors: Source Type: research